Search research articles
Contact Us
Filters
Showing results (61-70 of 67) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 67 results.
Cancer Research
|
June 13, 2000
DNA copy number changes in malignant ovarian germ cell tumors
S M Kraggerud, J Szymanska, V M Abeler, et al.
British Journal of Cancer
|
July 28, 2012
Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients
U Wagner, C Marth, R Largillier, et al.
Lancet (London, England)
|
February 24, 2001
Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma
I Vergote, J De Brabanter, A Fyles, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 6, 2003
First-line treatment of ovarian cancer FIGO stages IIb-IV with paclitaxel/epirubicin/carboplatin versus paclitaxel/carboplatin
G B Kristensen, I Vergote, G Stuart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 5, 1999
Long-term results from a phase II study of single agent paclitaxel (Taxol) in previously platinum treated patients with advanced ovarian cancer: the Nordic experience
C Tropé, T Hogberg, J Kaern, et al.
Journal of the National Cancer Institute
|
May 4, 2000
Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results
M J Piccart, K Bertelsen, K James, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 6, 2003
Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer
M J Piccart, K Bertelsen, G Stuart, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 67) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 67 results.
Cancer Research
|
June 13, 2000
DNA copy number changes in malignant ovarian germ cell tumors
S M Kraggerud, J Szymanska, V M Abeler, et al.
British Journal of Cancer
|
July 28, 2012
Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients
U Wagner, C Marth, R Largillier, et al.
Lancet (London, England)
|
February 24, 2001
Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma
I Vergote, J De Brabanter, A Fyles, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 6, 2003
First-line treatment of ovarian cancer FIGO stages IIb-IV with paclitaxel/epirubicin/carboplatin versus paclitaxel/carboplatin
G B Kristensen, I Vergote, G Stuart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 5, 1999
Long-term results from a phase II study of single agent paclitaxel (Taxol) in previously platinum treated patients with advanced ovarian cancer: the Nordic experience
C Tropé, T Hogberg, J Kaern, et al.
Journal of the National Cancer Institute
|
May 4, 2000
Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results
M J Piccart, K Bertelsen, K James, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 6, 2003
Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer
M J Piccart, K Bertelsen, G Stuart, et al.
Page
of 7